1023 / 1578
Department of Radiation Oncology
University Hospital Zurich
Chairman: Prof. Dr. Matthias Guckenberger
SBRT for
Prostate Cancer
Matthias Guckenberger
/
/
Question
Which answer is correct in prostate SBRT?
1. SBRT for prostate cancer is especially well
evaluated in high-risk disease.
2. Especially GI and not GU toxicity is an issue of
concern in SBRT for prostate cancer.
3. SBRT is using most frequently 5 fraction of doses
between 35 – 40Gy.
07.09.17
Matthias Guckenberger - ESTRO SBRT Course 2017
2